Histological evaluation of PAXgene tissue fixation in Barrett’s esophagus and esophageal adenocarcinoma diagnostics
暂无分享,去创建一个
M. Westerhoff | W. Weichert | J. Slotta-Huspenina | M. Vieth | M. Werner | Deepa T. Patil | J. Fléjou | M. Quante | K. Kamarádová | Julia Horstmann | K. Steiger | RolandM. Schmid | L. Fricke | K. Becker | M. P. Kumarasinghe | E. Kraynova | M. Barroux | Linus Schömig | Bruno Maerkel | Linus Schömig
[1] Po-Hsuan Cameron Chen,et al. Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge , 2022, Nature Medicine.
[2] T. Graham,et al. Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy , 2021, Nature Reviews Gastroenterology & Hepatology.
[3] A. Bass,et al. Abnormal TP53 Predicts Risk of Progression in Patients With Barrett’s Esophagus Regardless of a Diagnosis of Dysplasia , 2020, medRxiv.
[4] S. Killcoyne,et al. Genomic copy number predicts esophageal cancer years before transformation , 2020, Nature Medicine.
[5] Timo Kohlberger,et al. An augmented reality microscope with real-time artificial intelligence integration for cancer diagnosis , 2019, Nature Medicine.
[6] K. Strauch,et al. BarrettNET-a prospective registry for risk estimation of patients with Barrett's esophagus to progress to adenocarcinoma. , 2019, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[7] Thomas J. Fuchs,et al. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images , 2019, Nature Medicine.
[8] Jakob Nikolas Kather,et al. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer , 2019, Nature Medicine.
[9] H. El‐Serag,et al. Prior Diagnosis of Barrett’s Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival , 2018, Digestive Diseases and Sciences.
[10] Marcela A. Salomao,et al. Substantial Interobserver Agreement in the Diagnosis of Dysplasia in Barrett Esophagus Upon Review of a Patient’s Entire Set of Biopsies , 2017, The American journal of surgical pathology.
[11] J. Goldblum,et al. Discordance Among Pathologists in the United States and Europe in Diagnosis of Low-Grade Dysplasia for Patients With Barrett's Esophagus. , 2017, Gastroenterology.
[12] M. Ilyas,et al. Dysplasia in Barrett's oesophagus: p53 immunostaining is more reproducible than haematoxylin and eosin diagnosis and improves overall reliability, while grading is poorly reproducible , 2016, Histopathology.
[13] P. Martinez,et al. Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus , 2016, Nature Communications.
[14] Fay Betsou,et al. A Critical Evaluation of the PAXgene Tissue Fixation System: Morphology, Immunohistochemistry, Molecular Biology, and Proteomics. , 2016, American journal of clinical pathology.
[15] N. Shaheen,et al. Corrigendum: ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus , 2016, The American Journal of Gastroenterology.
[16] Kenneth K Wang,et al. Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis. , 2016, Gastroenterology.
[17] Nicholas J Shaheen,et al. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus , 2016, The American Journal of Gastroenterology.
[18] I. Tomlinson,et al. Genetic Biomarkers of Barrett’s Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis , 2015, Digestive Diseases and Sciences.
[19] S. El Hallani,et al. Evaluation of Quantitative Digital Pathology in the Assessment of Barrett Esophagus-Associated Dysplasia. , 2015, American journal of clinical pathology.
[20] Carissa A. Sanchez,et al. Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus , 2015, Cancer Prevention Research.
[21] Helen M. Moore,et al. Accuracy of Molecular Data Generated with FFPE Biospecimens: Lessons from the Literature. , 2015, Cancer research.
[22] Takeshi Yamaguchi,et al. Comprehensive DNA Methylation and Extensive Mutation Analyses of HER2-Positive Breast Cancer , 2015, Oncology.
[23] R. Fitzgerald,et al. Targeting care in Barrett's oesophagus. , 2014, Clinical medicine.
[24] Helen M. Moore,et al. A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded (FFPE) tissue: how well do you know your FFPE specimen? , 2014, Archives of pathology & laboratory medicine.
[25] G. Kayser,et al. Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial , 2014, Virchows Archiv.
[26] F. Vleggaar,et al. Surveillance of Barrett's Esophagus and Mortality from Esophageal Adenocarcinoma: A Population-Based Cohort Study , 2014, The American Journal of Gastroenterology.
[27] Rebecca C Fitzgerald,et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus , 2013, Gut.
[28] Stefan Heldmann,et al. MRI-compatible pipeline for three-dimensional MALDI imaging mass spectrometry using PAXgene fixation. , 2013, Journal of proteomics.
[29] Jorma Isola,et al. Preservation of nucleic acids and tissue morphology in paraffin-embedded clinical samples: comparison of five molecular fixatives , 2013, Journal of Clinical Pathology.
[30] K. Zatloukal,et al. The PAXgene® Tissue System Preserves Phosphoproteins in Human Tissue Specimens and Enables Comprehensive Protein Biomarker Research , 2013, PloS one.
[31] C. Compton,et al. Non-formalin fixative versus formalin-fixed tissue: a comparison of histology and RNA quality. , 2013, Experimental and molecular pathology.
[32] P. Riegman,et al. A new technology for stabilization of biomolecules in tissues for combined histological and molecular analyses. , 2012, The Journal of molecular diagnostics : JMD.
[33] L. Lovat,et al. Population-based study reveals new risk-stratification biomarker panel for Barrett's esophagus. , 2011, Gastroenterology.
[34] Kurt Zatloukal,et al. Histological Assessment of PAXgene Tissue Fixation and Stabilization Reagents , 2011, PloS one.
[35] H. Sørensen,et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. , 2011, The New England journal of medicine.
[36] Helen M. Moore,et al. Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue. , 2011, Archives of pathology & laboratory medicine.
[37] Prateek Sharma,et al. American Gastroenterological Association technical review on the management of Barrett's esophagus. , 2011, Gastroenterology.
[38] Kurt Zatloukal,et al. Proteomic analysis of PAXgene-fixed tissues. , 2010, Journal of proteome research.
[39] E. Espinosa,et al. Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues. , 2010, BioTechniques.
[40] Carissa A. Sanchez,et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma , 2006, Nature Genetics.
[41] J K Greenson,et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.
[42] M F Dixon,et al. The Vienna classification of gastrointestinal epithelial neoplasia , 2000, Gut.
[43] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[44] J. Fleiss,et al. Statistical methods for rates and proportions , 1973 .